Baba E - Search Results

1

In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.

Qin B, Tanaka R, Shibata Y, Arita S, Ariyama H, Kusaba H, Baba E, Harada M, Nakano S. Qin B, et al. Among authors: baba e. Anticancer Drugs. 2006 Apr;17(4):445-53. doi: 10.1097/01.cad.0000198912.98442.cd. Anticancer Drugs. 2006. PMID: 16550003

2

Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.

Kuroki M, Nakamura M, Itoyama Y, Tanaka Y, Shiraki H, Baba E, Esaki T, Tatsumoto T, Nagafuchi S, Nakano S, et al. Kuroki M, et al. Among authors: baba e. J Immunol. 1992 Aug 1;149(3):940-8. J Immunol. 1992. PMID: 1378869

3

A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.

Baba E, Nakamura M, Ohkuma K, Kira J, Tanaka Y, Nakano S, Niho Y. Baba E, et al. J Immunol. 1995 Jan 1;154(1):399-412. J Immunol. 1995. PMID: 7527817

4

Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.

Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, Niho Y. Baba E, et al. J Immunol. 1993 Jul 15;151(2):1013-24. J Immunol. 1993. PMID: 7687611

5

Sequence-dependent modulation of anticancer drug activities by 7-ethyl-10-hydroxycamptothecin in an HST-1 human squamous carcinoma cell line.

Masumoto N, Nakano S, Esaki T, Tatsumoto T, Fujishima H, Baba E, Nakamura M, Niho Y. Masumoto N, et al. Among authors: baba e. Anticancer Res. 1995 Mar-Apr;15(2):405-9. Anticancer Res. 1995. PMID: 7763013

6

Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.

Tanaka Y, Tanaka R, Terada E, Koyanagi Y, Miyano-Kurosaki N, Yamamoto N, Baba E, Nakamura M, Shida H. Tanaka Y, et al. Among authors: baba e. J Virol. 1994 Oct;68(10):6323-31. doi: 10.1128/JVI.68.10.6323-6331.1994. J Virol. 1994. PMID: 8083972 Free PMC article.

7

Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis.

Kamihira T, Shimoda S, Harada K, Kawano A, Handa M, Baba E, Tsuneyama K, Nakamura M, Ishibashi H, Nakanuma Y, Gershwin ME, Harada M. Kamihira T, et al. Among authors: baba e. Gastroenterology. 2003 Nov;125(5):1379-87. doi: 10.1016/j.gastro.2003.07.013. Gastroenterology. 2003. PMID: 14598254

8

Phase I study of CPT-11 and bolus 5-FU/ l-leucovorin in patients with metastatic colorectal cancer.

Fujishima H, Kikuchi I, Miyanaga O, Ueda A, Baba E, Mitsugi K, Harada M, Nakano S. Fujishima H, et al. Among authors: baba e. Int J Clin Oncol. 2004 Apr;9(2):92-7. doi: 10.1007/s10147-003-0371-3. Int J Clin Oncol. 2004. PMID: 15108040 Clinical Trial.

9

Protection against methotrexate toxicity by a soybean protein- and omega-3 fatty acid-containing diet: comparative study with a casein-containing diet.

Mitsugi K, Nakamura T, Kashiwabara N, Ariyama H, Tanaka R, Baba E, Nakamura M, Harada M, Nakano S. Mitsugi K, et al. Among authors: baba e. Oncol Rep. 2004 Jul;12(1):41-5. Oncol Rep. 2004. PMID: 15201956

10

In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.

Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S. Tanaka R, et al. Among authors: baba e. Cancer Chemother Pharmacol. 2005 Jun;55(6):595-601. doi: 10.1007/s00280-004-0966-z. Epub 2005 Feb 25. Cancer Chemother Pharmacol. 2005. PMID: 15731917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters